132 related articles for article (PubMed ID: 11367171)
1. Activism today: the Coalition for Salvage Therapy. Interview with Linda Grinberg. Interview by John S. James.
Grinberg L
AIDS Treat News; 1999 Nov; (No 330):2-4. PubMed ID: 11367171
[TBL] [Abstract][Full Text] [Related]
2. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
Sawyer E
AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
[TBL] [Abstract][Full Text] [Related]
3. AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James.
Bellman P
AIDS Treat News; 2000 Apr; (No 340):1-6. PubMed ID: 11367198
[TBL] [Abstract][Full Text] [Related]
4. Expanded and early access and patient assistance programs for other experimental drugs from their manufacturers.
Crit Path AIDS Proj; 1998; (No 33):43-64. PubMed ID: 11366373
[TBL] [Abstract][Full Text] [Related]
5. 1592: protests on small access program.
AIDS Treat News; 1997 Jun; (No 273):6-8. PubMed ID: 11364401
[TBL] [Abstract][Full Text] [Related]
6. A new approach for 'deep salvage' trials in advanced HIV infection.
Lederman MM; Miller V; Weller I; Deeks SG
AIDS; 2007 Jul; 21(12):1503-6. PubMed ID: 17630543
[TBL] [Abstract][Full Text] [Related]
7. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
[TBL] [Abstract][Full Text] [Related]
8. Antiretrovirals for the heavily experienced patient: hefty plans to holidays.
Martinez LJ
Res Initiat Treat Action; 1999 Oct; 5(4):5-8. PubMed ID: 11366942
[TBL] [Abstract][Full Text] [Related]
9. Children on losing end of access to new drugs.
AIDS Alert; 1998 Jan; 13(1):10-2. PubMed ID: 11364862
[TBL] [Abstract][Full Text] [Related]
10. Treatment interruption; advanced HIV; new ideas: Dr. Cal Cohen interview on retrovirus conference (part 2 or 2). Interview by John S. James.
Cohen C
AIDS Treat News; 2003 Apr; (390):2-5. PubMed ID: 12739473
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. FDA gives salvage therapy testing a push forward.
Bass E
AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Protease inhibitors and beyond: interview with David Feigal, M.D. Interview by John S James.
Feigal D
AIDS Treat News; 1995 Mar; (no 219):1-6. PubMed ID: 11362331
[TBL] [Abstract][Full Text] [Related]
15. [Salvage therapy in HIV infection].
Salzberger B
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():52, 54-5, 57. PubMed ID: 15373050
[TBL] [Abstract][Full Text] [Related]
16. AIDS in the Third World: how to stop the HIV infection?
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
[TBL] [Abstract][Full Text] [Related]
17. Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Delaugerre C; Peytavin G; Dominguez S; Marcelin AG; Duvivier C; Gourlain K; Amellal B; Legrand M; Raffi F; Costagliola D; Katlama C; Calvez V
J Med Virol; 2005 Nov; 77(3):345-50. PubMed ID: 16173015
[TBL] [Abstract][Full Text] [Related]
18. Challenge and co-operation: civil society activism for access to HIV treatment in Thailand.
Ford N; Wilson D; Cawthorne P; Kumphitak A; Kasi-Sedapan S; Kaetkaew S; Teemanka S; Donmon B; Preuanbuapan C
Trop Med Int Health; 2009 Mar; 14(3):258-66. PubMed ID: 19207173
[TBL] [Abstract][Full Text] [Related]
19. Removing US obstacles to AIDS healthcare.
Pelosi N
J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):32-4. PubMed ID: 11365087
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
